Surrogate testes: Allogeneic spermatogonial stem cell transplantation within an encapsulation device may restore male fertility

dc.contributor.authorGül, Murat
dc.contributor.authorDong, Lihua
dc.contributor.authorWang, Danyang
dc.contributor.authorDiri, Mehmet Akif
dc.contributor.authorAndersen, Claus Yding
dc.date.accessioned2020-09-24T06:10:54Z
dc.date.available2020-09-24T06:10:54Z
dc.date.issued2020
dc.departmentTıp Fakültesi
dc.descriptionDiri, Mehmet Akif ( Aksaray, Yazar )
dc.description.abstractToxic insult to the gonads by chemotherapy or radiotherapy can lead to permanent infertility. It’s an important health concern because each year more than 4000 male patients are at risk of azoospermia in the United States due to gonadotoxicity of the regimens used. There are also several benign/genetic diseases whose natural course can result in infertility without gonadotoxic therapy. Considering the fact that most of these people are cured and survive with the advent of modern medicine, infertility is related to serious psychological and relationship implications and parenthood is a significant issue for those patients. Semen cryopreservation option is available for postpubertal adolescent and adult men, while children do not have this storing option since they do not have mature spermatozoa. However, their testes contain spermatogonial stem cells (SSCs), which are initiators of spermatogenesis. Promising findings in animal studies and human cell lines have encouraged scientists that SSCs may be hope for restoring fertility option of patients who cannot produce functional sperm and who have no other choice to preserve their future fertility. For this reason, several centers around the world already began to collect and cryopreserve testicular tissue or cells with anticipation that SSC-based therapies will be available in the near future; however, an optimal transplantation design in humans is yet to be developed. Here we propose an allogeneic testicular stem cell transplantation with an encapsulation device to restore fertility in patients with infertility. We endeavor to discuss the reliability of this method with the current literature and bring the evidence on its feasibility.
dc.identifier.doi10.1016/j.mehy.2020.109634
dc.identifier.endpage-en_US
dc.identifier.issn0306-9877
dc.identifier.issue-en_US
dc.identifier.pmid32087491
dc.identifier.scopusqualityQ1
dc.identifier.startpage-en_US
dc.identifier.urihttps:/dx.doi.org/10.1016/j.mehy.2020.109634
dc.identifier.urihttps://hdl.handle.net/20.500.12451/7682
dc.identifier.volume139en_US
dc.identifier.wosWOS:000531083000019
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherChurchill Livingstone
dc.relation.ispartofMedical Hypotheses
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectSurrogate Testes
dc.subjectAllogeneic Spermatogonial
dc.titleSurrogate testes: Allogeneic spermatogonial stem cell transplantation within an encapsulation device may restore male fertility
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
gul-murat-2020.pdf
Boyut:
864.65 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: